Autopsy report · NCT04534010

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

“Sponsor decision due to low accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 3 years 7 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Breast Cancer

Interventions

NACgraft

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
  “Decision by funding sponsor due to poor accrual” (87% match in meaning)
• A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
  “Sponsor decision due to slow accrual” (85% match in meaning)
• The Effect of a Probiotic Strain on Aspirin-induced GI Damage
  “Decision made by Sponsor” (77% match in meaning)
• Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878
  “Sponsor decision” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.